While most stocks are up, the pullback on AI continues. The yield curve continues to steepen. Despite the somewhat dovish Fed cut on Wednesday, interest rates are moving higher today. The US 2-year ...

On the first day of the two-day-long marathon discussion in Lok Sabha on electoral reforms, Leader of Opposition Rahul Gandhi levelled charges of ‘vote theft’ against BJP and alleged that BJP in ...

Former Australian wicketkeeper Ian Healy expressed his disappointment with how England have played so far, calling their performance “deflating”, and suggested that a lack of preparation for ...

DETROIT -- For the past month, the Dallas Cowboys have carried with them the burden of losing a teammate and the joy of getting into playoff contention. On Thursday night, the Cowboys' 44-30 loss to ...

Sunday's home loss to the Buffalo Bills was one of the more disappointing losses the Pittsburgh Steelers have had in some time. Despite getting help from the Cincinnati Bengals on Thanksgiving and ...

The Indianapolis Colts were unable to finish off the Kansas City Chiefs, as their offense sputtered to end the game. An opportunity to capture a massive win over one of the AFC's elite turned into a ...

The Maduro Raid Was a Strategic Victory and a Tactical Success Why Is Louisiana Seeking to Rewrite the Past on American Energy Production? The West Must Start Preparing for Ukrainian Reconstruction ...

J.B. Hunt executives said on its Oct. 15 earnings call that tighter enforcement of driver licensing rules is accelerating capacity exits and could signal the end of the freight recession. The company ...

The New York Jets keep fumbling the football. Jets head coach Aaron Glenn tried to take the blame postgame instead of it being placed on Hall and the players. “I gotta figure out a way to get our guys ...

Many were optimistic that Kevin Durant would force his way to the Golden State Warriors before the 2024-25 season’s Feb. 6 trade deadline. The 15-time All-Star was linked to the Dubs on multiple ...

A phase 3 trial of aTyr Pharma’s efzofitimod in a lung disease has missed its primary endpoint. With a multibillion-dollar market in its sights, the biotech is planning to talk to the FDA about a path ...

Last week: Finally finished my replay of Metal Gear Solid 3 and decided it's easily the best one. Yesterday, a coworker shared a link to a little browser game that looked right up PC Gamer's alley: ...